BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $412,000 | -43.6% | 20,325 | -59.5% | 0.01% | -40.0% |
| Q3 2015 | $730,000 | -27.3% | 50,225 | +6.4% | 0.01% | -16.7% |
| Q2 2015 | $1,004,000 | +34.4% | 47,225 | +46.4% | 0.01% | +33.3% |
| Q1 2015 | $747,000 | +131.3% | 32,250 | +130.4% | 0.01% | +200.0% |
| Q4 2014 | $323,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |